Energean said it expected reserves at Cassiopea, which stood at 31 million barrels of oil equivalent at the end of 2024, ...
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is ...
In this analysis, my focus will be on developing a perspective on Cassiopea Sp.A.’s (SWX:SKIN) latest ownership structure, a less discussed, but important factor. When it comes to ownership structure ...
Sales revenue for the year declined 3.5% to USD1.72 billion from USD1.78 billion. Adjusted earnings before interest, tax, depreciation, and amortisation, and also before exploration expenses, fell 4.3 ...
Swiss-listed drugmaker Cassiopea said on Thursday it won approval for its first medicine, an acne treatment, from the U.S. Food and Drug Administration, setting the stage for a likely capital increase ...
It’s been decades since a novel acne treatment hit the scene, but that’s set to change with Cassiopea’s approval for Winlevi. The FDA on Thursday approved the new prescription acne medication, set for ...
LAINATE, Italy, Aug. 20, 2019 /PRNewswire/ -- Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to ...
Cassiopea is a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action to address long-standing and essential dermatological conditions, ...
Lainate, Italy - September 10, 2021: Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results